CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today announced the initiation of human clinical trials of Tyrima(TM), CeNeRx's new drug candidate with a triple mechanism of action for the treatment of depression and anxiety. [click link for full article]
More...